TNB Tech Minute: OpenAI Publishes New AI Policy Proposals
Share
Subscribe
Plus: federal regulators close investigation into Tesla’s autonomous summon feature. And Neurocrine Biosciences agrees to acquire Soleno Therapeutics for $2.9 billion. Danny Lewis hosts.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Plus: federal regulators close investigation into Tesla’s autonomous summon feature. And Neurocrine Biosciences agrees to acquire Soleno Therapeutics for $2.9 billion. Danny Lewis hosts.
Learn more about your ad choices. Visit megaphone.fm/adchoices
